Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Japanese Phase 1 Study of Mepolizumab [Phase 1]
This document reports the completion of a Japanese Phase 1 clinical trial evaluating mepolizumab for asthma.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers [Phase 1]
The update reports completion of a Phase 1 single-dose pharmacokinetics study of GSK2434735 in healthy male volunteers; asthma is listed as …
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of Ro 27-2441 as an inhaled corticosteroid replacement in moderate persistent asthma. The …
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids [Phase 2]
Phase 2 clinical trial evaluating various doses of Ro 27-2771 in asthma patients not treated with inhaled corticosteroids. The study status …
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD) [Phase 4]
Phase 4 clinical trial evaluating the efficacy of calcifediol supplementation for asthma control in asthmatic patients with vitamin D defici…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma [Phase 4]
Phase 4 clinical trial assessing the efficacy and safety of fluticasone propionate/salmeterol xinafoate delivered via an HFA MDI in pediatri…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: HFCS, Apple Juice, Excess Free Fructose & asthma-the FHS-OS
A completed clinical trial evaluating the relationship between high-fructose corn syrup, apple juice, and excess free fructose exposure in r…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma [Phase 1]
Phase 1 clinical efficacy study results for the salmeterol xinafoate/fluticasone propionate inhaler in asthma have been posted.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Bioequivalence Study of Montelukast 5 mg Chewable [Phase 1]
A Phase 1 bioequivalence study of Montelukast 5 mg chewable tablets for asthma has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects [Phase 1]
Phase 1 study evaluating bioavailability and pharmacokinetics of AZD7594 inhaled via different devices in healthy male subjects; results pos…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Bioequivalence Study of Montelukast 10 mg Tablets [Phase 1]
Phase 1 bioequivalence study of Montelukast 10 mg tablets has been completed, sponsored by GlaxoSmithKline for asthma.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects [Phase 1]
Phase 1 safety and pharmacokinetic study of the investigational compound GSK2190915 in healthy Japanese subjects has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler [Phase 1]
Phase 1 dose-proportionality study evaluating blood levels of Fluticasone Furoate and Vilanterol after different FF/VI inhaled doses in asth…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve [Phase 4]
Phase 4 trial update evaluating the effect of a long-acting muscarinic antagonist (LAMA) and an ultra-long-acting beta-agonist (uLABA) on th…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers. [Phase 1]
This Phase 1, blinded, dose-escalation study evaluated the pharmacokinetics, safety, and tolerability of repeat inhaled doses of GW870086X i…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: GSK2190915A - Bioavailability Study [Phase 1]
Phase 1 bioavailability study of GSK2190915A in asthma patients has been completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Investigation of Novel Procedure for Methacholine Challenge Testing [NA]
This document reports a completed clinical trial evaluating a novel methacholine challenge testing procedure in individuals with asthma.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma [Phase 3]
Phase 3 trial update comparing three inhaled corticosteroid/long-acting beta-agonist regimens for adults and adolescents with persistent ast…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) [Phase 1]
A Phase 1 study in asthma evaluated dose proportionality and absolute bioavailability of Fluticasone furoate inhalation powder delivered by …
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic study in healthy subjects comparing inhaled fluticasone furoate and GW642444 administered by inhalation and intraven…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination [Phase 1]
A Phase 1 bioequivalence study comparing Fluticasone Furoate 1-strip inhaler to a 2-strip inhaler and to the Fluticasone Furoate/Vilanterol …
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home [Phase 3]
This Phase 3 trial assessed whether patients can effectively use a pre-filled syringe to self-administer benralizumab at home, focusing on f…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI) [Phase 1]
This Phase 1 trial assessed pharmacokinetics and safety of a fixed-dose inhaled combination of fluticasone furoate and umeclidinium compared…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma [Phase 2]
Phase 2 trial evaluating dupilumab in patients with persistent moderate-to-severe eosinophilic asthma reports on efficacy, safety, and toler…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole [Phase 1]
A Phase 1 study evaluating the drug interaction between Fluticasone Furoate/GW642444 Inhalation Powder and ketoconazole in asthma patients h…